Related Experiment Video
Updated: Aug 18, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin
1Department of Psychiatry, College of Physicians & Surgeons, Columbia University, NY.
Abstract:
Several clinical studies have suggested that patients with affective disorder are at high risk for developing tardive dyskinesia (TD). An intriguing aspect of the relationship between TD and affective disorders involves mood dependent alterations in the severity of TD in bipolar patients. In most reported cases, depressive episodes have been reported to be associated with exacerbation of TD, while manic episodes were accompanied by attenuation of TD. Current neurochemical hypotheses of TD do not explain adequately the relationship of TD to depression or mania in bipolar patients. A patient with bipolar illness is presented in whom TD emerged concurrently with the onset of depression that developed during management of an acute manic episode. It is suggested that decline in melatonin secretion with onset of the depression was associated with the emergence of TD. Thus, the increased incidence and risk of TD in bipolar patients may in part be related to decreased melatonin secretion, while increased melatonin secretion during manic episodes may have protective effect against the development of TD.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...

